컴퍼니케이

307930KOSDAQ기타 금융업

55.4 / 100

Reference Date: 2026-07-24

Financial Score20.0 / 40

News Sentiment18.4 / 25

Momentum7.0 / 20

Disclosure10.0 / 15

AI Analysis: the debt ratio is very low with excellent financial health but PBR raises overvaluation concerns. Slightly up 3.6% over the past month, and news sentiment is positive.

Company InformationBased on 2025 Annual Report

Business Overview

Company K is a venture capital firm specializing in providing investment financing to SMEs and startups, with core business operations including fund formation, investment management, and investment recovery. Major fund contributors include policy institutions and financial institutions, while investment targets focus on early-stage ventures with strong technological potential but limited capital and management resources.

Number of Employees

28people

Average Salary

129.7M KRW

Score Calculation Basis

Detailed Financial Score

PER

12.96Industry Average 7.941.5Point

1.6x industry avg (risky)

PBR

1.14Industry Average 0.450.0Point

2.5x industry avg (risky)

ROE

9.25Industry Average 5.455.5Point

1.7x industry avg (good)

Debt Ratio

6.70Industry Average 16.996.5Point

Half of industry avg (excellent)

Trend 2023~20256.5 / 10 points

Revenue Growth Rate

2.5 / 3

Avg ▲19.2% (2-year basis)

Operating Profit Growth Rate

3.0 / 3

Avg ▲182.7% (2-year basis)

ROE Trend

1.0 / 4

Avg ROE 1.5% (improving, 3yr)

Detailed News Sentiment

10 totalPositive 7Neutral 3Negative 0Average Sentiment Score 73.5

Positive
프레이저테라퓨틱스, J&J 산하 VC 등에서 투자 유치 [VC 브리핑]
컴퍼니케이 관련 투자 유치 소식으로 인해 긍정적인 시장 반응 예상.
Positive
[단독] 코스모비, 60억원 시리즈A 유치…'스타링크 기술' 국산화 나...
컴퍼니케이 관련 투자 유치 소식으로 인해 컴퍼니케이의 기술 파트너십 강화와 관련 산업 성장 기대감 증가.
Positive
프레이저테라퓨틱스, 500억원 유치…美 실리콘밸리 VC 합류
컴퍼니케이 관련 뉴스는 없으나, 프레이저테라퓨틱스의 대규모 투자 유치는 관련 바이오 산업에 긍정적 영향을 미칠 것으로 예상됩니다.

Detailed Momentum

52-week position1.0Point

Near 52w low (10%, downtrend)

Current 6,010Won52-week high 10,66052-week low 5,440

1-month return4.0Point

1m +3.62% (slight rise)

Volume trend2.0Point

Volume decreasing

Detailed Disclosure

2 totalPositive 0Neutral 2Negative 0

Neutral주주명부폐쇄기간또는기준일설정2026-07-16
Neutral주주총회소집결의 (임시주주총회)2026-07-16